Evidence map›Paper›PMID 32732333›Full record

ArticleThe European respiratory journal2020

Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.

Antoine Beurnier, Etienne-Marie Jutant, Mitja Jevnikar, Athénaïs Boucly, Jérémie Pichon, Mariana Preda, Marie Frank, Jérémy Laurent, Christian Richard, Xavier Monnet and 13 more

Open access · hybridAbstract read
In one paragraph

Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 9 pooled it
2.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 9 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: Systematic review and meta-analysis.The Journal of asthma : official journal of the Association for the Care of Asthma · 2022
    Pooled it
  4. The impact of comorbid allergic airway disease on the severity and mortality of COVID-19: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Asthma in patients with coronavirus disease 2019: A systematic review and meta-analysis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021
    Pooled it
  9. Pooled it
  10. Trial
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors at 3 institutions in 1 country.

Antoine BeurnierUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Etienne-Marie JutantUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Mitja JevnikarUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Athénaïs BouclyUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Jérémie PichonUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Mariana PredaUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Marie FrankAP-HP, Département d'information médicale, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Jérémy LaurentAP-HP, Département d'information médicale, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Christian RichardUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Xavier MonnetUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Jacques DuranteauUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Anatole HarroisUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Marie-Camille ChaumaisUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Marie-France BellinUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Nicolas NoëlUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Sophie BulifonUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Xavier JaïsUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Florence ParentUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Andrei SeferianUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.
Laurent SavaleUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-6862-8975
Olivier SitbonUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-1942-1951
David MontaniUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0002-9358-6922
Marc HumbertUniversité Paris-Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0003-0703-2892
Inserm · FRUniversité Paris-Saclay · FRAssistance Publique – Hôpitaux de Paris · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundViral respiratory infections are the main causes of asthma exacerbation. The susceptibility of patients with asthma to develop an exacerbation when they present with severe pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is unknown. The objective of this study was to investigate the characteristics and outcomes of asthmatic patients with coronavirus disease 2019 (COVID-19) pneumonia who required hospitalisation during the spring 2020 outbreak in Paris, France.

methodsA prospective cohort follow-up was carried out from 15 March to 15 April 2020 in Bicêtre Hospital, University Paris-Saclay, France. All hospitalised patients with a SARS-CoV-2 infection who reported a history of asthma were included.

resultsAmong 768 hospitalised patients, 37 (4.8%) reported a history of asthma, which had been previously confirmed by a pulmonologist in 85% of cases. These asthmatic patients were mainly female (70%) and nonsmokers (85%), with a median age of 54 years (interquartile range (IQR) 42-67 years). None of them presented with an asthma exacerbation. 22 (59%) had major comorbidities and 31 (84%) had a body mass index ≥25 kg·m

conclusionAsthma patients were not overrepresented among those with severe pneumonia due to SARS-CoV-2 infection who required hospitalisation. The worst outcomes were observed mainly in patients with major comorbidities.

Indexed as

BetacoronavirusHospitalizationAdultAgedAnti-Asthmatic AgentsAsthmaCohort StudiesCoronavirus InfectionsCOVID-19FemaleFranceHumansMaleMiddle AgedOutcome Assessment, Health CarePandemicsAnti-Asthmatic Agents

Identifiers

PMID32732333
PMCPMC7397950
OpenAlexW3046375353

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.